ArticleOncotarget2020

TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.

Marie D Ralff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.